These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29684996)
1. Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37. Mastrangelo F; Frydas I; Ronconi G; Kritas SK; Tettamanti L; Caraffa Al; D Ovidio C; Younes A; Gallenga CE; Conti P J Biol Regul Homeost Agents; 2018; 32(2):195-198. PubMed ID: 29684996 [TBL] [Abstract][Full Text] [Related]
2. Impact of mast cells in fibromyalgia and low-grade chronic inflammation: Can IL-37 play a role? Conti P; Gallenga CE; Caraffa A; Ronconi G; Kritas SK Dermatol Ther; 2020 Jan; 33(1):e13191. PubMed ID: 31837249 [TBL] [Abstract][Full Text] [Related]
3. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition. Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489 [TBL] [Abstract][Full Text] [Related]
4. Status of immune mediators in fibromyalgia. Gur A; Oktayoglu P Curr Pain Headache Rep; 2008 Jun; 12(3):175-81. PubMed ID: 18796266 [TBL] [Abstract][Full Text] [Related]
5. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
6. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37. Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657 [TBL] [Abstract][Full Text] [Related]
7. Fibromyalgia and cytokines. Rodriguez-Pintó I; Agmon-Levin N; Howard A; Shoenfeld Y Immunol Lett; 2014 Oct; 161(2):200-3. PubMed ID: 24462815 [TBL] [Abstract][Full Text] [Related]
18. Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Togo F; Natelson BH; Adler GK; Ottenweller JE; Goldenberg DL; Struzik ZR; Yamamoto Y Exp Biol Med (Maywood); 2009 Feb; 234(2):232-40. PubMed ID: 19064941 [TBL] [Abstract][Full Text] [Related]
19. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines. Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470 [TBL] [Abstract][Full Text] [Related]
20. Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain--interleukin-8 in fibromyalgia and interleukin-1 β in rheumatoid arthritis. Kosek E; Altawil R; Kadetoff D; Finn A; Westman M; Le Maître E; Andersson M; Jensen-Urstad M; Lampa J J Neuroimmunol; 2015 Mar; 280():49-55. PubMed ID: 25773155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]